a company, which engages in the development and distribution of regenerative and respiratory medicine and treatments
Industry MedicalSpecialties
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GBCIX | 19.54 | -0.14 | -0.71% |
Gabelli Dividend Growth I | |||
BPSCX | 28.13 | -0.34 | -1.19% |
Boston Partners Small Cap Value II Inv | |||
PNOPX | 134.43 | -2.26 | -1.65% |
Putnam Sustainable Leaders A | |||
JSGCX | 26.15 | -0.54 | -2.02% |
JHancock U.S. Growth C | |||
TNRAX | 18.13 | -0.38 | -2.05% |
1290 Avantis U.S. Large Cap Growth A |
A.I.dvisor indicates that over the last year, RCEL has been loosely correlated with BLFS. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if RCEL jumps, then BLFS could also see price increases.
Ticker / NAME | Correlation To RCEL | 1D Price Change % | ||
---|---|---|---|---|
RCEL | 100% | -5.01% | ||
BLFS - RCEL | 38% Loosely correlated | -2.91% | ||
MRCHF - RCEL | 38% Loosely correlated | N/A | ||
AZTA - RCEL | 34% Loosely correlated | -2.62% | ||
LUNG - RCEL | 33% Loosely correlated | -1.71% | ||
VCYT - RCEL | 32% Poorly correlated | -2.97% | ||
More |